« Back to Record
Citation APA

Eskens, F. A., Awada, A., Cutler, D. L., de Jonge, M. J., Luyten, G. P., Faber, M., Statkevich, P., Sparreboom, A., Verweij, J., Hanauske, A.-R., Piccart-Gebhart, M., & European Organization for Research and Treatment of Cancer Early Clinical Studies Group, (2001). Phase I and pharmacokinetic study of the oral farnesyl transferase inhibitor SCH 66336 given twice daily to patients with advanced solid tumors. Journal of clinical oncology, 19(4), 1167-1175.


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/53682

Eskens, F. A., Awada, A., Cutler, D. L., de Jonge, M. J., Luyten, G. P., Faber, M., Statkevich, P., Sparreboom, A., Verweij, J., Hanauske, A.-R., Piccart-Gebhart, M., & European Organization for Research and Treatment of Cancer Early Clinical Studies Group, (2001). Phase I and pharmacokinetic study of the oral farnesyl transferase inhibitor SCH 66336 given twice daily to patients with advanced solid tumors. Journal of clinical oncology, 19(4), 1167-1175.